Penobscot Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$224K Sell
446
-3
-0.7% -$1.44K 0.06% 111
2026
Q1
$221K Hold
449
0.07% 103
2025
Q4
$260K Buy
449
+24
+6% +$13.6K 0.08% 87
2025
Q3
$206K Buy
+425
New +$198K 0.07% 102
2025
Q2
Sell
-465
Closed -$231K 100
2025
Q1
$231K Buy
465
+37
+9% +$20K 0.1% 79
2024
Q4
$223K Buy
428
+9
+2% +$4.95K 0.1% 71
2024
Q3
$259K Buy
419
+7
+2% +$4.14K 0.14% 67
2024
Q2
$223K Buy
412
+7
+2% +$4.01K 0.13% 67
2024
Q1
$235K Buy
405
+2
+0.5% +$1.12K 0.15% 66
2023
Q4
$214K Hold
403
0.14% 68
2023
Q3
$204K Buy
+403
New +$215K 0.15% 63

Other funds holding TMO

Penobscot Wealth Management's TMO Position: Q2 2026 in Review

Penobscot Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 0.67% in Q2 2026, selling an estimated $1.44K and leaving 446 shares worth $224K. The position accounts for 0.06% of the portfolio, ranked #111.

Penobscot Wealth Management first reported a position in TMO in Q3 2023 and has held it in 11 quarters since. The position peaked at $260K in Q4 2025. 440 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Penobscot Wealth Management held 446 shares of Thermo Fisher Scientific worth $224K as of Q2 2026.
  • Penobscot Wealth Management sold 3 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.44K.
  • Thermo Fisher Scientific made up 0.06% of Penobscot Wealth Management's portfolio in Q2 2026, its #111 holding.
  • Penobscot Wealth Management first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 11 quarters since.
  • Penobscot Wealth Management's Thermo Fisher Scientific position peaked at $260K in Q4 2025.
  • 440 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Penobscot Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.